(FLXI) Franklin Libertyshares ICAV - Ratings and Ratios

Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE00BHZRQZ17

FLXI: Shares, Indian, Equities, Index, Tracker, Germany, Investors

The Franklin Libertyshares ICAV - Franklin FTSE India UCITS ETF is an exchange-traded fund listed on XETRA, providing investors with exposure to the Indian equity market. The fund tracks the Morningstar India TME NR USD Index, which is a benchmark designed to measure the performance of the Indian equity market.

As an India Equity ETF, FLXI offers a diversified portfolio of Indian stocks, allowing investors to tap into the growth potential of the Indian economy. With a Assets Under Management (AUM) of approximately 603.97 million EUR, the fund has a sizable presence in the market. The funds investment objective is to replicate the performance of the underlying index, providing investors with a efficient and cost-effective way to gain exposure to the Indian equity market.

From a technical analysis perspective, the current price of 39.33 is slightly above the 20-day and 50-day Simple Moving Averages (SMA) of 39.24 and 39.27, respectively, indicating a neutral short-term trend. However, the 200-day SMA at 40.64 is above the current price, suggesting a potential long-term downtrend. The Average True Range (ATR) of 0.41, or 1.04%, indicates a relatively stable volatility profile. Considering the 52-week high and low of 43.98 and 36.56, respectively, the current price is near the lower end of the range, suggesting potential support.

Combining the technical and fundamental data, a forecast for FLXI could be as follows: given the current neutral short-term trend and the potential long-term downtrend, we can expect the price to be influenced by the overall market conditions. However, with the AUM of 603.97 million EUR, the fund is relatively stable, and the Indian equity market is expected to grow in the long term. Therefore, we can forecast a potential price target of 42.00 in the next 6-12 months, assuming a stable market conditions and a recovery in the Indian equity market. Conversely, a decline below 38.00 could indicate a further decline, potentially testing the 52-week low.

Additional Sources for FLXI ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

FLXI ETF Overview

Market Cap in USD 706m
Category India Equity
TER 0.19%
IPO / Inception 2019-06-25

FLXI ETF Ratings

Growth Rating 51.4
Fundamental -
Dividend Rating 0.0
Rel. Strength -29.8
Analysts -
Fair Price Momentum 39.62 EUR
Fair Price DCF -

FLXI Dividends

Currently no dividends paid

FLXI Growth Ratios

Growth Correlation 3m 38.1%
Growth Correlation 12m -78.2%
Growth Correlation 5y 90.7%
CAGR 5y 15.84%
CAGR/Max DD 5y 0.82
Sharpe Ratio 12m -0.64
Alpha -15.74
Beta 0.333
Volatility 13.62%
Current Volume 31.9k
Average Volume 20d 29.7k
What is the price of FLXI shares?
As of June 28, 2025, the stock is trading at EUR 39.56 with a total of 31,854 shares traded.
Over the past week, the price has changed by +1.87%, over one month by -0.70%, over three months by -0.28% and over the past year by -7.80%.
Is Franklin Libertyshares ICAV a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, Franklin Libertyshares ICAV (XETRA:FLXI) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 51.38 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FLXI is around 39.62 EUR . This means that FLXI is currently overvalued and has a potential downside of 0.15%.
Is FLXI a buy, sell or hold?
Franklin Libertyshares ICAV has no consensus analysts rating.
What are the forecasts for FLXI share price target?
According to our own proprietary Forecast Model, FLXI Franklin Libertyshares ICAV will be worth about 43.7 in June 2026. The stock is currently trading at 39.56. This means that the stock has a potential upside of +10.41%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 43.7 10.4%